Royal Sense Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Royal Sense Ltd is ₹ 69.95 as of 22 Oct 15:30 . The P/E Ratio of Royal Sense Ltd is 34 as of March 2024 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2024 . The Market Cap of Royal Sense Ltd is ₹ 53.9 crore as of March 2024 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2024 . The revenue of Royal Sense Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Royal Sense Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Royal Sense Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Royal Sense Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 8 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 8 years .

About Royal Sense Ltd

Royal Sense Limited was incorporated as a Public Limited Company pursuant to a Certificate of Incorporation dated April 06, 2023, issued by the Registrar of Companies, Central Registration Centre.
Prior to the incorporation of Company, the Promoter Rishabh Arora was running the business in sole proprietorships under the name 'M/s Royal Traders, M/s PHT & M/s Anaya'. In 2015, the Company started their business under proprietorship as M/s Royal Traders; in 2018 as M/s PHT and proprietorship as M/s Anaya in 2020.
Later on, April 28, 2023, the running business of the aforesaid proprietorship concern was acquired by the Company, along with the assets and liabilities of the proprietorship concern as going concern.
The Company has absorbed the business line & distribution network of firms. 'RoyalSense' is the suppliers of high quality goods that meet international standards required for hospitals, laboratories, institutions and clinics to provide health services.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Royal Sense Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Royal Sense Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Royal Sense Ltd is 37 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Royal Sense Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Royal Sense Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Royal Sense Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 24, 2026, the Royal Sense Ltd stock price is INR ₹69.95. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Royal Sense Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Royal Sense Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.